Home
>
National Drug Code (NDC)
>
RINKEL MOLD MIX B
RINKEL MOLD MIX B - 54575-229-10 - (trichothecium roseum and passalora fulva and cochliobolus spicifer and myrothecium verrucaria and trichophyton schoenleinii and mycogone nigra and neurospora crassa and khuskia oryzae and paecilomyces)
Drug Information of RINKEL MOLD MIX B
| Product NDC: | 54575-229 |
| Proprietary Name: | RINKEL MOLD MIX B |
| Non Proprietary Name: | trichothecium roseum and passalora fulva and cochliobolus spicifer and myrothecium verrucaria and trichophyton schoenleinii and mycogone nigra and neurospora crassa and khuskia oryzae and paecilomyces |
| Active Ingredient(s): | .071; .072; .071; .072; .071; .071; .071; .072; .071; .072; .072; .072; .071; .071 g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL & nbsp; trichothecium roseum and passalora fulva and cochliobolus spicifer and myrothecium verrucaria and trichophyton schoenleinii and mycogone nigra and neurospora crassa and khuskia oryzae and paecilomyces |
| Administration Route(s): | PERCUTANEOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of RINKEL MOLD MIX B
| Product NDC: | 54575-229 |
| Labeler Name: | Allergy Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA101376 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19671207 |
Package Information of RINKEL MOLD MIX B
| Package NDC: | 54575-229-10 |
| Package Description: | 10 mL in 1 VIAL, MULTI-DOSE (54575-229-10) |
NDC Information of RINKEL MOLD MIX B
| NDC Code | 54575-229-10 |
| Proprietary Name | RINKEL MOLD MIX B |
| Package Description | 10 mL in 1 VIAL, MULTI-DOSE (54575-229-10) |
| Product NDC | 54575-229 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | trichothecium roseum and passalora fulva and cochliobolus spicifer and myrothecium verrucaria and trichophyton schoenleinii and mycogone nigra and neurospora crassa and khuskia oryzae and paecilomyces |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | PERCUTANEOUS; SUBCUTANEOUS |
| Start Marketing Date | 19671207 |
| Marketing Category Name | BLA |
| Labeler Name | Allergy Laboratories, Inc. |
| Substance Name | COCHLIOBOLUS SPICIFER; HELMINTHOSPORIUM SOLANI; KHUSKIA ORYZAE; MICROASCUS BREVICAULIS; MYCOGONE NIGRA; MYROTHECIUM VERRUCARIA; NEUROSPORA CRASSA; PAECILOMYCES VARIOTII; PASSALORA FULVA; PLEOSPORA TARDA; STREPTOMYCES GRISEUS; TRICHODERMA VIRIDE; TRICHOPHYTON SCHOENLEINII; TRICHOTHECIUM ROSEUM |
| Strength Number | .071; .072; .071; .072; .071; .071; .071; .072; .071; .072; .072; .072; .071; .071 |
| Strength Unit | g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL |
| Pharmaceutical Classes | Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Bacterial Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Bacterial Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient] |
